New research reveals that glial cells, specifically oligodendrocytes, produce amyloid beta, a protein linked to Alzheimer’s disease, challenging the long-held belief that neurons are the sole contributors. This discovery opens new possibilities for therapies aimed at preventing plaque formation in the brain. Targeting both neurons and glial cells could slow the disease’s progression by inhibiting amyloid beta production before plaques form.